AVITA Medical, Inc. (RCEL) stock

RCELNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as AVHHL

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30

$15.63−0.57 (-3.52%)

Close on Nov 13, 2026Market cap $483.39MP/E –Yield –

AVITA Medical price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

AVITA Medical's price to sales ratio was 7.1× on Nov 11, 2026, against 1.6× a year earlier. Over the last 5 years it ranged from 1.4× to 17.5×, with a median of 4.9×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	7.1×	+5.6
2025	Dec 31, 2025	1.5×	−4.1
2024	Dec 31, 2024	5.6×	−6.4
2023	Dec 29, 2023	12.0×	+6.4
2022	Dec 30, 2022	5.6×	−4.6
2021	Dec 31, 2021	10.2×	−14.8
2020	Dec 31, 2020	25.0×	−75.7
2019	Dec 31, 2019	100.7×	+44.5
2018	Dec 31, 2018	56.2×	–

Where these numbers come from

Parsed from the XBRL in AVITA Medical's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-5 reverse split on Jun 30, 2020
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing